Skip to main content
All lobbying filings

CONTINENTAL STRATEGY, LLC

Lobbying for DEXCOM · Healthcare company that develops, manufactures, produces, and distributes CGMs.

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 19, 2026
Income
$75,000.00
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 1
  • Executive Office of the President (EOP)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Health Issues

continuous glucose monitoring

Medical/Disease Research/Clinical Labs

continuous glucose monitoring

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem